InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by GOWER BOB G, Director. Officer active across 1 company, notably Ensysce Biosciences, Inc.. Cumulatively, 5 reports have been logged. Split: 3 buys · 0 sell. Total volume traded: €565k. Activity tracked since 9 December 2022. The latest transaction was filed on 2 March 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations5 total
90,287 shares@ US$0.48837.3% of flowCommon StockSEC:0001493152-23-006786:0
Ideal exit: 27 Nov 2023 (T+270)
109,300 shares@ US$0.48838.9% of flowCommon StockSEC:0001493152-23-006553:0
Ideal exit: 25 Nov 2023 (T+270)
357,143 shares@ US$1.4083.8% of flowCommon StockSEC:0001493152-23-003343:0
Ideal exit: 5 Sept 2023 (T+270)
7,919,026 sharesCommon StockSEC:0001192482-21-000620:0
7,919,026 sharesCommon StockSEC:0001192482-21-000620
5 of 5 declarations
About GOWER BOB G
Bob G. Gower is a board member of Ensysce Biosciences, Inc. In this role, he is involved in overseeing the company's operations and guiding its strategic direction. With experience in the biotechnology sector, he contributes to decision-making that impacts Ensysce's performance and growth. His expertise is a valuable asset to the company.
